Previous studies have shown that RAB1A is elevated in the progression of human cancers and associated with a poor prognosis in patients with cancers such as lung cancer [20], colorectal cancer [21], intrahepatic cholangiocarcinoma [22], gastric cancer [23], and bladder cancer [24]. Here, RAB1A is linked to urinary bladder carcinoma.